Literature DB >> 12643156

Diagnosis and management of diabetic neuropathy.

Bruce A Perkins1, Vera Bril.   

Abstract

Diabetic sensorimotor polyneuropathy (DSP) remains the most common microvascular complication of both type I and type 2 diabetes, and poses a unique set of management challenges in the prevention of foot complications. Although different quantitative tests are available, the preliminary diagnosis of DSP can be reliably made using simple and rapid screening tests in the family physician's office or in the diabetes clinic. The Semmes-Weinstein 10-g monofilament examination is a popular, simple clinical modality for the prediction of early DSP, foot ulceration, and amputation, and, in turn, a predictor of mortality in patients with diabetes. The management of DSP is centered on optimal glycemic control, diligent foot care, and pain control as a means of preventing the progression of DSP and reducing the morbidity associated with foot complications.

Entities:  

Mesh:

Year:  2002        PMID: 12643156     DOI: 10.1007/s11892-002-0119-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  63 in total

1.  Evaluation of pressure threshold prior to foot ulceration: one-versus two-point static touch.

Authors:  M A Barber; J Conolley; C M Spaulding; A L Dellon
Journal:  J Am Podiatr Med Assoc       Date:  2001 Nov-Dec

2.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Authors:  H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

3.  Identification of patients at risk for diabetic foot: a comparison of standardized noninvasive testing with routine practice at community diabetes clinics.

Authors:  A Jirkovská; P Boucek; V Wosková; V Bartos; J Skibová
Journal:  J Diabetes Complications       Date:  2001 Mar-Apr       Impact factor: 2.852

4.  'Numbness of the feet' is a poor indicator for polyneuropathy in Type 2 diabetic patients.

Authors:  L V Franse; G D Valk; J H Dekker; R J Heine; J T van Eijk
Journal:  Diabet Med       Date:  2000-02       Impact factor: 4.359

5.  Total neuropathy score: validation and reliability study.

Authors:  D R Cornblath; V Chaudhry; K Carter; D Lee; M Seysedadr; M Miernicki; T Joh
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

6.  The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes.

Authors:  P R Olmos; S Cataland; T M O'Dorisio; C A Casey; W L Smead; S R Simon
Journal:  Am J Med Sci       Date:  1995-02       Impact factor: 2.378

7.  Painful neuropathy and foot ulceration in diabetic patients.

Authors:  A Veves; C Manes; H J Murray; M J Young; A J Boulton
Journal:  Diabetes Care       Date:  1993-08       Impact factor: 19.112

8.  Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.

Authors:  I Tkac; V Bril
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112

Review 9.  The burden of diabetic foot ulcers.

Authors:  G E Reiber; B A Lipsky; G W Gibbons
Journal:  Am J Surg       Date:  1998-08       Impact factor: 2.565

10.  Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy.

Authors:  A J Boulton; F A Gries; J A Jervell
Journal:  Diabet Med       Date:  1998-06       Impact factor: 4.359

View more
  9 in total

Review 1.  Islet versus pancreas transplantation in type 1 diabetes: competitive or complementary?

Authors:  Barbara Ludwig; Stefan Ludwig; Anja Steffen; Hans-Detlev Saeger; Stefan R Bornstein
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

Review 2.  The effect of whole organ pancreas transplantation and PIT on diabetic complications.

Authors:  Timothy C Lee; Neal R Barshes; Erin E Agee; Christine A O'Mahoney; F Charles Brunicardi; John A Goss
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

3.  A stiff price to pay: does joint stiffness predict disability in an older population?

Authors:  Manu Thakral; Ling Shi; Robert H Shmerling; Jonathan F Bean; Suzanne G Leveille
Journal:  J Am Geriatr Soc       Date:  2014-10       Impact factor: 5.562

4.  EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.

Authors:  Zhao Zhong Chong; Jinling Hou; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2011-05       Impact factor: 1.990

Review 5.  Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus.

Authors:  Kenneth Maiese; Simona Daniela Morhan; Zhao Zhong Chong
Journal:  Curr Neurovasc Res       Date:  2007-02       Impact factor: 1.990

6.  Bilateral limbic system destruction in man.

Authors:  Justin S Feinstein; David Rudrauf; Sahib S Khalsa; Martin D Cassell; Joel Bruss; Thomas J Grabowski; Daniel Tranel
Journal:  J Clin Exp Neuropsychol       Date:  2010-01       Impact factor: 2.475

7.  Hyperglycemia-Induced Oxidative-Nitrosative Stress Induces Inflammation and Neurodegeneration via Augmented Tuberous Sclerosis Complex-2 (TSC-2) Activation in Neuronal Cells.

Authors:  Premranjan Kumar; Thiagarajan Raman; Mitali Madhusmita Swain; Rangnath Mishra; Arttatrana Pal
Journal:  Mol Neurobiol       Date:  2016-01-06       Impact factor: 5.590

Review 8.  Mechanistic insights into diabetes mellitus and oxidative stress.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

Review 9.  "Sly as a FOXO": new paths with Forkhead signaling in the brain.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang
Journal:  Curr Neurovasc Res       Date:  2007-11       Impact factor: 1.990

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.